@misc{indiciaec53fa7ff7ee0,
  title = {Functional testing of PI3K inhibitors stratifies responders to idelalisib and identifies treatment vulnerabilities in idelalisib-refractory/intolerant chronic lymphocytic leukemia},
  author = {Yin, Y. and Athanasiadis, P. and Karlsen, L. and Urban, A. and Murali, I. and Fernandes, S. M. and Arribas, A. J. and Hilli, A. K. and Tasken, K. and Bertoni, F. and Mato, A. R. and Normant, E. and Brown, J. R. and Tjonnfjord, G. E. and Aittokallio, T. and Skanland, S. S.},
  year = {2022},
  doi = {10.1101/2022.04.14.488428},
  url = {https://www.biorxiv.org/content/10.1101/2022.04.14.488428v1},
  note = {Source identifier: 10.1101/2022.04.14.488428}
}